ad image

Community

KshitiJ (TJ) Ladage
KshitiJ (TJ) Ladage

Market Research Analysis Director, Nice Insight

Kshitij (TJ) has been a part of Nice Insight since 2014. TJ’s role involves research design and operations, developing and maintaining syndicated studies, business intelligence data analysis, content development and article writing on the latest developments in the biopharmaceutical industry. Prior to market research, TJ spent time in academia research working on a broad range of subject matter, including pharmacoeconomics, drug delivery and genetics. TJ holds a masters of biotechnology degree from the University of Pennsylvania.
17 Contributions1 / 1
Using Blockchain to Drive Drug Development and Healthcare Data Management
Blockchain

Using Blockchain to Drive Drug Development and Healthcare Data Management

KshitiJ (TJ) Ladage

Nice Insight

PAO-04-21-NI-01Apr 12, 2021
Blockchain: Increasing Efficiency and Transparency Across the Supply Chain
Blockchain

Blockchain: Increasing Efficiency and Transparency Across the Supply Chain

KshitiJ (TJ) Ladage

Nice Insight

PAO-03-21-NI-03Mar 29, 2021
Approved Therapeutics for a Novel Pandemic: Drug Repurposing to Treat COVID-19
Research Insights

Approved Therapeutics for a Novel Pandemic: Drug Repurposing to Treat COVID-19

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q3-20-NI-011Sep 29, 2020
COVID-19 and Europe: Driving Nationalism Rather than Solidarity
COVID-19

COVID-19 and Europe: Driving Nationalism Rather than Solidarity

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q2-20-NI-003Jul 01, 2020
How Close Is CRISPR to Eradicating Disease and Correcting Genetic Defects?
CRISPR-Cas9

How Close Is CRISPR to Eradicating Disease and Correcting Genetic Defects?

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q1-20-NI-003Mar 19, 2020
Choosing the Right Expression Platform for Biologics
Expression Systems

Choosing the Right Expression Platform for Biologics

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q3-19-NI-005Oct 28, 2019
Collaborating for Immunotherapy Development
Immunotherapy

Collaborating for Immunotherapy Development

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q1-2019-NI-007Mar 12, 2019
Regulatory Spotlight: FDA Delays Enforcement of Serialization Mandate
Serialization

Regulatory Spotlight: FDA Delays Enforcement of Serialization Mandate

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q4-18-NI-011Oct 26, 2018
Combining Content and Research in a Single Website Platform
Insightful Integration

Combining Content and Research in a Single Website Platform

Emilie Branch; KshitiJ (TJ) Ladage

Pharma's Almanac

PAP-Q3-17-NI-001Sep 15, 2017
Incorporating QbD into Lyophilization Manufacturing

Incorporating QbD into Lyophilization Manufacturing

KshitiJ (TJ) Ladage

Nice Insight

CPO-M09-16-NI-001Dec 04, 2016
Nice Insight Launches 2017 Study Season

Nice Insight Launches 2017 Study Season

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q04-16-NI-001Oct 01, 2016
Nice Insight Pharmaceutical Equipment 2016 Annual Study

Nice Insight Pharmaceutical Equipment 2016 Annual Study

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q02-16-NI-003Apr 01, 2016
Equipment Trends Transforming Pharmaceutical Manufacturing

Equipment Trends Transforming Pharmaceutical Manufacturing

KshitiJ (TJ) Ladage

Nice Insight

PAP-Q1-16-EQ-001Feb 01, 2016
From Cell Culture to Cell Therapy – Drug Applications Continue To Surge As Science Grows

From Cell Culture to Cell Therapy – Drug Applications Continue To Surge As Science Grows

KshitiJ (TJ) Ladage

Nice Insight

PA5640Sep 30, 2015
Selecting An Outsourcing Partner For Vaccine Production

Selecting An Outsourcing Partner For Vaccine Production

KshitiJ (TJ) Ladage

Nice Insight

ICO-M03-15-NI-001Mar 04, 2015
What Does 2015 Hold For The Indian CMO Industry?

What Does 2015 Hold For The Indian CMO Industry?

KshitiJ (TJ) Ladage

Nice Insight

LSL-M03-15-NI-003Mar 03, 2015
Bioreactor Preferences from an Outsourcing Perspective – Part I

Bioreactor Preferences from an Outsourcing Perspective – Part I

KshitiJ (TJ) Ladage

Nice Insight

PMP-M02-15-NI-001Feb 05, 2015
1 / 1